[1]
Phase I/II trial of immunogenicity of a human papillomavirus (HPV) type 16 E7 protein–based vaccine in women with oncogenic HPV-positive cervical intraepithelial neoplasia.[J]..Cancer Immunology; Immunotherapy.2004, 7
[1]
Phase I/II trial of immunogenicity of a human papillomavirus (HPV) type 16 E7 protein–based vaccine in women with oncogenic HPV-positive cervical intraepithelial neoplasia.[J]..Cancer Immunology; Immunotherapy.2004, 7